33 related articles for article (PubMed ID: 11696049)
1. Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.
Macglashan DW; Saini SS
J Allergy Clin Immunol; 2013 Oct; 132(4):906-11.e1-4. PubMed ID: 23791510
[TBL] [Abstract][Full Text] [Related]
2. Association of a SYK promoter polymorphism with SYK expression and IgE-mediated histamine release.
MacGlashan D; Gao L
Clin Exp Allergy; 2023 May; 53(5):573-576. PubMed ID: 36722389
[No Abstract] [Full Text] [Related]
3. CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease.
Gong W; Yu J; Zheng T; Liu P; Zhao F; Liu J; Hong Z; Ren H; Gu G; Wang G; Wu X; Zhao Y; Ren J
Clin Transl Med; 2021 Feb; 11(2):e339. PubMed ID: 33634985
[TBL] [Abstract][Full Text] [Related]
4. FceRI density and spontaneous secretion from human basophils.
MacGlashan D
PLoS One; 2017; 12(7):e0179734. PubMed ID: 28671980
[TBL] [Abstract][Full Text] [Related]
5. Basophil Stimulation and Signaling Pathways.
Knol EF; Gibbs BF
Methods Mol Biol; 2020; 2163():311-322. PubMed ID: 32766986
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effects of type-A procyanidins polyphenols from cinnamon bark in compound 48/80-induced mast cell degranulation.
Kandhare AD; Aswar UM; Mohan V; Thakurdesai PA
Anat Cell Biol; 2017 Dec; 50(4):275-283. PubMed ID: 29354299
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.
Zaidi AK; Saini SS; Macglashan DW
J Allergy Clin Immunol; 2010 Apr; 125(4):902-908.e7. PubMed ID: 20236696
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.
Bhavaraju K; Kim S; Daniel JL; Kunapuli SP
Eur J Pharmacol; 2008 Feb; 580(3):285-90. PubMed ID: 18068154
[TBL] [Abstract][Full Text] [Related]
9. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway.
Oliver JM; Kepley CL; Ortega E; Wilson BS
Immunopharmacology; 2000 Jul; 48(3):269-81. PubMed ID: 10960668
[TBL] [Abstract][Full Text] [Related]
10. Targeting Syk as a treatment for allergic and autoimmune disorders.
Wong BR; Grossbard EB; Payan DG; Masuda ES
Expert Opin Investig Drugs; 2004 Jul; 13(7):743-62. PubMed ID: 15212616
[TBL] [Abstract][Full Text] [Related]
11. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs.
Miura K; Lavens-Phillips S; MacGlashan DW
Clin Exp Allergy; 2001 Nov; 31(11):1732-9. PubMed ID: 11696049
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the free cytosolic calcium timelag following IgE-mediated stimulation of human basophils: significance for the nonreleasing basophil phenotype.
MacGlashan D; Lavens-Phillips S
J Leukoc Biol; 2001 Feb; 69(2):224-32. PubMed ID: 11272272
[TBL] [Abstract][Full Text] [Related]
13. Localizing a control region in the pathway to leukotriene C(4) secretion following stimulation of human basophils with anti-IgE antibody.
Miura K; Lavens-Phillips S; MacGlashan DW
J Immunol; 2001 Dec; 167(12):7027-37. PubMed ID: 11739523
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
[TBL] [Abstract][Full Text] [Related]
15. Induced loss of Syk in human basophils by non-IgE-dependent stimuli.
MacGlashan DW; Ishmael S; MacDonald SM; Langdon JM; Arm JP; Sloane DE
J Immunol; 2008 Mar; 180(6):4208-17. PubMed ID: 18322233
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
